Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Béziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, Staal J, Aschenbrenner D, Roels L, Worley L, Claes K, Gartner L, Kohn LA, De Bruyne M, Schmitz-Abe K, Charbonnier LM, Keles S, Nammour J, Vladikine N, Maglorius Renkilaraj MRL, Seeleuthner Y, Migaud M, Rosain J, Jeljeli M, Boisson B, Van Braeckel E, Rosenfeld JA, Dai H, Burrage LC, Murdock DR, Lambrecht BN, Avettand-Fenoel V, Vogel TP; Undiagnosed Diseases Network, Esther CR, Haskologlu S, Dogu F, Ciznar P, Boutboul D, Ouachée-Chardin M, Amourette J, Lebras MN, Gauvain C, Tcherakian C, Ikinciogullari A, Beyaert R, Abel L, Milner JD, Grimbacher B, Couderc LJ, Butte MJ, Freeman AF, Catherinot É, Fieschi C, Chatila TA, Tangye SG, Uhlig HH, Haerynck F, Casanova JL, Puel A.

J Exp Med. 2020 Jun 1;217(6). pii: e20191804. doi: 10.1084/jem.20191804.

PMID:
32207811
2.

Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma.

Marçais A, Cook L, Witkover A, Asnafi V, Avettand-Fenoel V, Delarue R, Cheminant M, Sibon D, Frenzel L, de Thé H, Bangham CRM, Bazarbachi A, Hermine O, Suarez F.

Retrovirology. 2020 Mar 21;17(1):5. doi: 10.1186/s12977-020-0513-y.

3.

Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

Frange P, Tubiana R, Sibiude J, Canestri A, Arvieux C, Brunet-Cartier C, Cotte L, Reynes J, Mandelbrot L, Warszawski J, Le Chenadec J; ANRS EPF CO1/CO11 Study Group .

J Antimicrob Chemother. 2020 Mar 11. pii: dkaa017. doi: 10.1093/jac/dkaa017. [Epub ahead of print]

PMID:
32157283
4.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

Marcellin F, Di Beo V, Aumaitre H, Mora M, Wittkop L, Duvivier C, Protopopescu C, Lacombe K, Esterle L, Berenger C, Gilbert C, Bouchaud O, Poizot-Martin I, Sogni P, Salmon-Ceron D, Carrieri P; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2020 Mar;72(3):588-591. doi: 10.1016/j.jhep.2019.10.019. Epub 2020 Jan 7. No abstract available.

PMID:
31924411
5.

High rates of antiretroviral coverage and virological suppression in HIV-1-infected children and adolescents.

Soumah A, Avettand-Fenoel V, Veber F, Moshous D, Mahlaoui N, Blanche S, Frange P.

Med Mal Infect. 2019 Nov 10. pii: S0399-077X(19)31056-X. doi: 10.1016/j.medmal.2019.10.006. [Epub ahead of print]

PMID:
31722862
6.

The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.

Henriquez S, Lécuroux C, Bitu M, Avettand-Fenoel V, Churaqui F, Catalan P, Chéret A, Boufassa F, Saez-Cirion A, Monceaux V, Meyer L, Goujard C, Lambotte O, Bourgeois C; ANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts.

AIDS. 2019 Nov 15;33(14):2137-2147. doi: 10.1097/QAD.0000000000002342.

PMID:
31688039
7.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

Visseaux B, Assoumou L, Mahjoub N, Grude M, Trabaud MA, Raymond S, Wirden M, Morand-Joubert L, Roussel C, Montes B, Bocket L, Fafi-Kremer S, Amiel C, De Monte A, Stefic K, Pallier C, Tumiotto C, Maillard A, Vallet S, Ferre V, Bouvier-Alias M, Dina J, Signori-Schmuck A, Carles MJ, Plantier JC, Meyer L, Descamps D, Chaix ML; AC43 ANRS Resistance Group .

J Antimicrob Chemother. 2020 Jan 1;75(1):183-193. doi: 10.1093/jac/dkz404.

PMID:
31641777
8.

HIV controllers: to treat or not to treat? Is that the right question?

Noël N, Saez-Cirion A, Avettand-Fenoël V, Boufassa F, Lambotte O.

Lancet HIV. 2019 Dec;6(12):e878-e884. doi: 10.1016/S2352-3018(19)30264-4. Epub 2019 Oct 14. Review.

PMID:
31624011
9.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V; CODEX ANRS Cohort Study Group .

Clin Infect Dis. 2019 Sep 21. pii: ciz734. doi: 10.1093/cid/ciz734. [Epub ahead of print]

PMID:
31541253
10.

Cell and tissue reservoirs of HIV-1: dynamics during infection.

Trémeaux P, Rouzioux C, Avettand-Fènoël V.

Virologie (Montrouge). 2019 Aug 1;23(4):211-228. doi: 10.1684/vir.2019.0784.

PMID:
31414659
11.

Viral reservoirs, a challenging theme in HIV research.

Avettand-Fènoël V.

Virologie (Montrouge). 2019 Aug 1;23(4):193-194. doi: 10.1684/vir.2019.0781. No abstract available.

PMID:
31414657
12.

The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.

Henriquez S, Lecuroux C, Bitu M, Avettand-Fenoel V, Churaqui F, Catalan P, Cheret A, Boufassa F, Saez-Cirion A, Monceaux V, Meyer L, Goujard C, Lambotte O, Bourgeois C; ANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts.

AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002342. [Epub ahead of print]

PMID:
31385864
13.

Genital Human Immunodeficiency Virus-1 RNA and DNA Shedding in Virologically Suppressed Individuals Switching From Triple- to Dual- or Monotherapy: Pooled Results From 2 Randomized, Controlled Trials.

Hocqueloux L, Gubavu C, Prazuck T, De Dieuleveult B, Guinard J, Sève A, Mille C, Gardiennet E, Lopez P, Rouzioux C, Lefeuvre S, Avettand-Fènoël V.

Clin Infect Dis. 2019 Jul 11. pii: ciz511. doi: 10.1093/cid/ciz511. [Epub ahead of print]

PMID:
31350995
14.

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).

Santos ME, Protopopescu C, Sogni P, Yaya I, Piroth L, Bailly F, Marcellin F, Esterle L, Wittkop L, Rosenthal E, Morlat P, Roux P, de Araujo WN, Salmon-Ceron D, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

AIDS Behav. 2020 Apr;24(4):1069-1084. doi: 10.1007/s10461-019-02585-7.

PMID:
31286317
15.

HIV-mediated immune aging in young adults infected perinatally or during childhood.

Fastenackels S, Sauce D, Vigouroux C, Avettand-Fènoël V, Bastard JP, Fellahi S, Nailler L, Arezes E, Rouzioux C, Warszawski J, Viard JP, Appay V; ANRS Co19 COVERTE Study Group.

AIDS. 2019 Sep 1;33(11):1705-1710. doi: 10.1097/QAD.0000000000002275.

16.

Similar efficacy and safety of dolutegravir between age groups of HIV-1-infected paediatric and young adult patients aged 5 years and older.

Frange P, Avettand-Fenoel V, Veber F, Blanche S.

HIV Med. 2019 Sep;20(8):561-566. doi: 10.1111/hiv.12752. Epub 2019 May 29.

PMID:
31140725
17.

Temporal virus serological profiling of kidney graft recipients using VirScan.

Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10899-10904. doi: 10.1073/pnas.1821166116. Epub 2019 May 13.

18.

Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.

Trémeaux P, Lenfant T, Boufassa F, Essat A, Mélard A, Gousset M, Delelis O, Viard JP, Bary M, Goujard C, Rouzioux C, Meyer L, Avettand-Fenoel V; ANRS-SEROCO and PRIMO cohorts.

EBioMedicine. 2019 Mar;41:455-464. doi: 10.1016/j.ebiom.2019.02.016. Epub 2019 Feb 23.

19.

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments.

Kula A, Delacourt N, Bouchat S, Darcis G, Avettand-Fenoel V, Verdikt R, Corazza F, Necsoi C, Vanhulle C, Bendoumou M, Burny A, De Wit S, Rouzioux C, Rohr O, Van Lint C.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):605-613. doi: 10.1097/QAI.0000000000001958.

PMID:
30768485
20.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.

Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D; ANRS AC-43 Resistance Study Group.

J Antimicrob Chemother. 2019 May 1;74(5):1417-1424. doi: 10.1093/jac/dkz011.

PMID:
30753724

Supplemental Content

Loading ...
Support Center